Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Sell
49,993
-1,485
-3% -$402K 1.51% 17
2025
Q4
$15.2M Buy
51,478
+1,485
+3% +$445K 1.55% 15
2025
Q3
$14.1M Sell
49,993
-4
-0% -$1.05K 1.53% 16
2025
Q2
$14.7M Buy
49,997
+4
+0% +$1.03K 1.67% 15
2025
Q1
$12.4M Buy
+49,993
New +$12.2M 1.71% 14
2024
Q4
Sell
-50,146
Closed -$11.1M 372
2024
Q3
$11.1M Buy
50,146
+123
+0.2% +$24.1K 1.62% 16
2024
Q2
$8.65M Sell
50,023
-32
-0.1% -$5.56K 1.39% 15
2024
Q1
$9.56M Sell
50,055
-99
-0.2% -$18.1K 1.72% 13
2023
Q4
$8.2M Buy
+50,154
New +$7.58M 1.47% 12
2023
Q3
Sell
-1,656
Closed -$222K 147
2023
Q2
$222K Buy
+1,656
New +$214K 0.07% 125
2020
Q1
Sell
-1,925
Closed -$247K 74
2019
Q4
$247K Hold
1,925
0.13% 66
2019
Q3
$268K Sell
1,925
-680
-26% -$91.7K 0.15% 62
2019
Q2
$343K Buy
+2,605
New +$342K 0.16% 65

Other funds holding IBM

Cynosure Group's IBM Position: Q1 2026 in Review

Cynosure Group reduced its IBM (IBM) stake by 2.9% in Q1 2026, selling an estimated $402K and leaving 49,993 shares worth $12.1M. The position accounts for 1.51% of the portfolio, ranked #17.

Cynosure Group first reported a position in IBM in Q2 2019 and has held it in 13 quarters since. The position peaked at $15.2M in Q4 2025. 3,466 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Cynosure Group held 49,993 shares of IBM worth $12.1M as of Q1 2026.
  • Cynosure Group sold 1,485 IBM shares in Q1 2026, an estimated $402K.
  • IBM made up 1.51% of Cynosure Group's portfolio in Q1 2026, its #17 holding.
  • Cynosure Group first reported a position in IBM in Q2 2019 and has held it in 13 quarters since.
  • Cynosure Group's IBM position peaked at $15.2M in Q4 2025.
  • 3,466 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.